Latest AI and machine learning research in leukemia for healthcare professionals.
Leukemia cell image classification is challenged by real-world domain shifts from acquisition, staining, illumination, and site protocols, causing single-dataset models to generalize poorly in real clinical scenarios. This work presents a robust framework for leukemia classification across multiple heterogeneous datasets using a two-stage pipeline with a pretrained vision foundation model. Stage 1...
Breast cancer (BC) is the second most common noncutaneous cancer and the second leading cause of cancer-related death in women. BC is classified into three primary subtypes, with triple-negative breast cancer (TNBC) having the poorest prognosis because it lacks specific targetable markers. Preclinical studies on TNBC indicated a common occurrence of diminished tumor-suppressor activity of PTEN, ac...
Single-cell foundation models have recently emerged as a promising approach for learning general-purpose representations from large-scale transcriptom...
Discovery of pathway associations and druggability can leverage underutililized dark kinase genes for treating complex diseases (proven for cancer and...
There has been significant interest in using machine learning algorithms to predict kidney transplant outcomes, such as the number of years until a gr...
The accurate segmentation of lizard claws is important as they are materially heterogeneous, comprising both bone and keratinous tissue. This study pr...
Single-cell RNA sequencing has enabled the construction of comprehensive cell atlases, yet the quality and coherence of the cell-type annotations with...
Preformed and de novo antibodies against donor human leukocyte antigen (HLA) antigens remain a major cause of antibody-mediated rejection and graft lo...
Background. Pediatric musculoskeletal trauma represents up to 18% of pediatric ED visits, yet diagnosis still depends on ionizing radiography. Cumulat...
Inferring "whether a change in the expression of a given gene causally affects the disease state" from observational single-cell transcriptomic data i...
CD19 targeted chimeric antigen receptor (CAR) T cell therapy achieves high initial response rates in B cell acute lymphoblastic leukemia (B ALL), yet ...
To advance our understanding of drug action in physiologically-relevant systems, we developed a high-throughput transcriptomic atlas of compound respo...
Rising costs, slow accrual and molecular substratification of cancers necessitate novel clinical trial designs. We demonstrate that artificial intelli...
Aphasia following stroke commonly produces systematic naming errors with characteristic profiles, but whether general-purpose language models not desi...
Computational modeling of cellular behavior - the virtual cell - has emerged as a stated grand challenge at the intersection of artificial intelligenc...
Background. Diagnosis and risk stratification in rare hematologic malignancies such as myeloproliferative neoplasms (MPNs) - polycythemia vera (PV), e...
We present DynaVelo, a generative neural ordinary differential equation model that learns the joint dynamics of gene expression and transcription fact...
Predicting drug sensitivity across diverse cancer cell lines remains a fundamental challenge in precision oncology, particularly for data-scarce cell ...
Three audiences -- the family of a newly diagnosed Ewing sarcoma patient, the long-term survivor, and the cooperative-group trial statistician -- rece...
Background Pretreatment prediction of primary resistance to anti-PD-(L)1 therapy in advanced non-small-cell lung cancer (NSCLC) remains an unmet clini...